Core Viewpoint - Guilin Sanjin (002275) has completed the revision and re-registration of its main traditional Chinese medicine product instructions, ensuring that the new regulations will not affect the normal market sales of its products [1] Company Summary - The company has successfully updated the instructions for its key traditional Chinese medicine products [1] - Re-registration of these products has been completed, indicating compliance with regulatory requirements [1] - The company assures that the new regulations will not disrupt the normal sales process of its products [1]